For the first time ever in the world medical practice a bioregulation therapy has been designed and put into practice for restoring and maintaining main functions of the organs and tissues throughout the genetically determined span of human life (110-120 years). The complex of measures aimed at preventing age-related pathology, holding back ageing and thus extending the life span up to the specific limit is based on the administration of peptide bioregulators.